How should I manage a patient with severe, intractable abdominal pain and CT evidence of colitis?

Management of Intractable Abdominal Pain with CT-Confirmed Colitis

Admit the patient immediately for inpatient management, initiate IV corticosteroids (hydrocortisone 100 mg every 6 hours or methylprednisolone 60 mg daily), obtain urgent stool studies including C. difficile testing, and arrange flexible sigmoidoscopy within 48 hours while consulting surgery early if peritoneal signs, toxic megacolon, or pericolic fluid are present. 1, 2

Immediate Risk Stratification & Admission Criteria

Hospitalize any patient meeting acute severe colitis criteria: ≥6 bloody stools per day plus any of the following—temperature >37.8°C, heart rate >90 bpm, hemoglobin <105 g/L, or CRP >30 mg/L. 1, 2

• Pericolic fluid on CT is a high-risk marker indicating severe colonic inflammation that mandates immediate surgical consultation alongside medical therapy. 2
• Examine for peritoneal signs (severe pain, rebound tenderness, guarding, hypoactive bowel sounds)—their presence suggests impending perforation or toxic megacolon and triggers emergency surgical evaluation. 2
• CT features predicting higher mortality include colonic wall thickness >4 mm, pericolic fat stranding, ascites, pneumatosis intestinalis, or free intra-abdominal air. 2
• Measure transverse colon diameter on imaging—dilation >5.5 cm defines toxic megacolon and requires urgent surgical consultation. 2

Diagnostic Workup (Do Not Delay Treatment)

Obtain baseline labs immediately: complete blood count, CRP, urea/electrolytes, liver function tests, magnesium, and albumin. 1, 2

• Send comprehensive stool studies for bacterial cultures (Salmonella, Shigella, Campylobacter, E. coli), C. difficile toxin assay, and ova/parasites. 1, 2, 3
• Do not wait for stool results to start therapy—initiate treatment as soon as acute severe colitis is suspected. 1, 2
• Perform flexible sigmoidoscopy within 48 hours to obtain biopsies for histology, assess for CMV infection (especially in immunocompromised patients), and identify deep ulceration (a poor-prognosis marker). 1, 2
• Avoid full colonoscopy in fulminant colitis because of heightened perforation risk. 1, 2

Initial Medical Management

Start IV corticosteroids immediately after fluid resuscitation: hydrocortisone 100 mg every 6 hours OR methylprednisolone 60–80 mg daily. 1, 2, 4

• Provide thromboprophylaxis with low-molecular-weight heparin for all admitted patients—rectal bleeding is not a contraindication. 1, 2
• Withhold 5-ASA agents during the acute phase of severe colitis. 2
• If C. difficile cannot be confidently excluded, add empiric oral vancomycin 125 mg four times daily while awaiting test results. 2
• Correct dehydration and replace potassium (≥60 mmol/day) and magnesium losses to prevent hypokalaemia and toxic dilatation. 1, 2
• Avoid antiperistaltic agents and opiates to prevent toxic megacolon. 2

Daily Monitoring & Response Assessment

Conduct daily senior gastroenterology review, repeat labs (FBC, U&E, CRP), and perform daily abdominal examinations. 1, 2

• Day-3 response assessment is critical: >8 bowel movements/day OR 3–8 movements/day with CRP >45 mg/L predicts ~85% chance of steroid failure, indicating need for rescue therapy. 1, 2
• Obtain plain abdominal X-ray on alternate days to monitor for colonic dilation. 4
• Record temperature and pulse four times daily to detect systemic toxicity. 4

Rescue Therapy for Steroid Failure

If inadequate response by day 3–5, initiate rescue therapy with infliximab 5 mg/kg IV at weeks 0,2, and 6 OR cyclosporine 2 mg/kg/day IV. 1, 2, 5

• Most patients who have not convincingly responded within 10 days of full medical therapy should undergo colectomy, although partial responders who are afebrile may continue for up to 14 days. 4
• Do not delay rescue therapy beyond day 5—patients remaining on ineffective corticosteroids suffer high morbidity and delayed surgery. 2

Absolute Indications for Emergency Surgery

Consult surgery immediately if any of the following develop:

• Radiographic free air indicating colonic perforation. 2
• Toxic megacolon (colonic dilation with severe systemic inflammation) without improvement after 24–48 hours of maximal medical therapy. 2
• Hemodynamic instability or septic shock despite optimal medical therapy. 2
• Severe ileus with vomiting, absent stool passage, and markedly dilated bowel loops. 2
• Clinical deterioration after 3–5 days of maximal medical treatment. 2
• Serum lactate >5.0 mmol/L, a marker of severe disease warranting urgent colectomy. 2

Special Considerations for Infectious Colitis

If C. difficile is confirmed and the patient is already on steroids, add oral vancomycin 500 mg every 6 hours for 10 days while continuing corticosteroids. 2

• For non-C. difficile bacterial colitis, stop unnecessary antibiotics promptly to reduce recurrence risk. 2
• Provide supportive care with IV fluids, electrolyte replacement, and maintain hemoglobin >10 g/dL. 2

Diverticulitis-Specific Management (If CT Suggests This Etiology)

For uncomplicated diverticulitis, conservative treatment without antibiotics is appropriate in immunocompetent patients. 1

• Use antibiotics for ≤7 days in immunocompromised/elderly patients with uncomplicated diverticulitis. 1
• For small diverticular abscesses, antibiotic therapy alone for 7 days is sufficient. 1
• For large diverticular abscesses, combine percutaneous drainage with antibiotic therapy for 4 days. 1

Common Pitfalls to Avoid

• Do not use topical corticosteroids as first-line therapy—they are less effective than topical mesalazine in ulcerative colitis. 2, 3
• Do not postpone corticosteroid therapy while awaiting stool microbiology when the clinical picture strongly suggests inflammatory colitis. 2, 3
• Do not delay surgical consultation—involve surgery from admission in severe cases. 2
• Avoid NSAIDs—they can exacerbate colonic inflammation. 2, 3

Prognostic Factors

Low hemoglobin, albumin <30 g/L, and elevated lactate are linked to higher rates of surgery, ICU admission, and mortality. 2

• Endoscopic deep ulceration predicts poorer outcomes and increased colectomy rates. 2
• CRP/albumin ratio >0.85 combined with stool frequency >3 per day confers a 74% risk of treatment failure. 2
• Approximately 20–30% of acute severe colitis patients require colectomy during the same admission. 1, 2
• Overall mortality of acute severe colitis is 1%, but significantly higher in patients >60 years and those with comorbidities. 1, 2